Biotransformation enzymes in human intestine: critical low levels in the colon?
- PMID: 1902809
- PMCID: PMC1379081
- DOI: 10.1136/gut.32.4.408
Biotransformation enzymes in human intestine: critical low levels in the colon?
Abstract
Biotransformation or drug-metabolising enzymes have an important function in the detoxication of ingested toxic, carcinogenic, or tumour promoting compounds. Enzyme activity and isoenzyme composition of three biotransformation systems: glutathione S-transferase, uridine diphosphate-glucuronosyltransferase, and cytochrome P-450 were studied in normal small and large intestinal mucosa from three kidney donors. The activity of most drug-metabolising enzymes decreases slightly from proximal to distal small intestine, whereas in the mucosa of the large intestine a sharp fall in activity was observed. The isoenzyme composition for each of the three biotransformation systems changed from the small to the large intestine. Class Alpha glutathione S-transferases were not expressed in the colon, in contrast to the small intestine where both Alpha and Pi class isoenzymes are present. In addition, with monoclonal antibodies fewer protein bands for UDP-glucuronosyltransferases and cytochrome P-450 were detected in the colon. In the small intestine both isoforms P-450(4) and P-450(5) were present, whereas in the colon only reduced amounts of cytochrome P-450(4) could be visualised. For UDP-glucuronosyltransferase, 53 and 54 kDa proteins could be detected in the small intestine, but in the colon there was only weak staining of the 54 kDa band. In the normal human colon enzymes are less active and there are fewer isoenzymes present in the mucosa than in the small intestine. This implies a lower level of the detoxifying potential in the colon, which might be important in regard to the high rates of carcinogenesis in the colon.
Similar articles
-
Glutathione S-transferase, cytochrome P450, and uridine 5'-diphosphate-glucuronosyltransferase in human small intestine and liver.Gastroenterology. 1989 Mar;96(3):783-9. Gastroenterology. 1989. PMID: 2492479
-
Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems.Cancer Res. 1992 Dec 1;52(23):6567-75. Cancer Res. 1992. PMID: 1423302
-
Xenobiotic metabolising enzyme expression in colonic neoplasia.Gut. 1993 Sep;34(9):1234-9. doi: 10.1136/gut.34.9.1234. Gut. 1993. PMID: 8406161 Free PMC article.
-
Biotransformation of xenobiotics in the human colon and rectum and its association with colorectal cancer.Drug Metab Rev. 2015 May;47(2):199-221. doi: 10.3109/03602532.2014.996649. Epub 2015 Feb 17. Drug Metab Rev. 2015. PMID: 25686853 Review.
-
Cytochrome P450-mediated metabolism in the human gut wall.J Pharm Pharmacol. 2009 May;61(5):541-58. doi: 10.1211/jpp/61.05.0002. J Pharm Pharmacol. 2009. PMID: 19405992 Review.
Cited by
-
Extrahepatic metabolism of zidovudine.Br J Clin Pharmacol. 1992 Feb;33(2):190-2. doi: 10.1111/j.1365-2125.1992.tb04024.x. Br J Clin Pharmacol. 1992. PMID: 1550699 Free PMC article.
-
Extrahepatic metabolism of drugs in humans.Clin Pharmacokinet. 1994 Feb;26(2):144-60. doi: 10.2165/00003088-199426020-00007. Clin Pharmacokinet. 1994. PMID: 8162658 Review.
-
Mutual interactions between flavonoids and enzymatic and transporter elements responsible for flavonoid disposition via phase II metabolic pathways.RSC Adv. 2012 Sep 21;2(21):7948-7963. doi: 10.1039/C2RA01369J. RSC Adv. 2012. PMID: 25400909 Free PMC article.
-
Synthesis and evaluation of mesoporous carbon/lipid bilayer nanocomposites for improved oral delivery of the poorly water-soluble drug, nimodipine.Pharm Res. 2015 Jul;32(7):2372-83. doi: 10.1007/s11095-015-1630-5. Epub 2015 Jan 22. Pharm Res. 2015. PMID: 25609013
-
Human colonocyte detoxification.Gut. 1997 Dec;41(6):731-4. doi: 10.1136/gut.41.6.731. Gut. 1997. PMID: 9462203 Free PMC article. Review. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous